← Browse by Condition
Medical Condition

nafld

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1

ClinicalMetric tracks all active clinical trials for nafld sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — nafld Clinical Trials

How many clinical trials are currently recruiting for nafld?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for nafld, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for nafld?
nafld research spans Phase 1 (1 trial), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a nafld clinical trial?
Eligibility criteria for nafld trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 2
2
Top Sponsors
University of Nottingham 1 trial
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1 trial
Ain Shams University 1 trial
Ziekenhuis Oost-Limburg 1 trial
VA Office of Research and Development 1 trial

Recruiting Clinical Trials

NCT07093346
Recruiting
The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Enrollment
45 pts
Location
United Kingdom
Sponsor
University of Nottingham
View Trial →
NCT06879236
Recruiting
Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver Disease
Enrollment
252 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT05984745 Phase 2
Recruiting
Effect of CoQ10 on the Outcome of MAFLD Patients
Enrollment
60 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →
NCT06445361
Recruiting
Prevalence of NAFLD in T1DM Patients
Enrollment
138 pts
Location
Belgium
Sponsor
Ziekenhuis Oost-Limburg
View Trial →
NCT06671886
Recruiting
NAFLD Clinical Care Pathway
Enrollment
32 pts
Location
United States
Sponsor
VA Office of Research and Deve...
View Trial →
NCT06599918 Phase 2
Recruiting
Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)
Enrollment
30 pts
Location
Spain
Sponsor
Fundació Institut de Recerca d...
View Trial →
NCT05979389 Phase 1
Recruiting
Bicalutamide Therapy in Young Women With NAFLD and PCOS
Enrollment
50 pts
Location
United States
Sponsor
University of California, San ...
View Trial →

Related Conditions

masld (2) nafld nonalcoholic fatty liver disease (2) nafld non alcoholic fatty liver disease (2) fatty liver (2) nonalcoholic fatty liver disease (1) nonalcoholic fatty liver disease nafld (1) masld metabolic dysfunction associated steatotic liver disease (1) metabolic dysfunction associated steatotic liver disease (1) nash (1) type 1 diabetes (1) fatty liver nonalcoholic (1) obesity (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology